Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer-Reference-Cited by-同舟云学术

Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer

Published:2016-01 Issue:1 Volume:15 Page:154-163
ISSN:1535-9476
Container-title:Molecular & Cellular Proteomics
language:en
Short-container-title:Molecular & Cellular Proteomics

Author:

Ren Shancheng,Shao Yaping,Zhao Xinjie,Hong Christopher S.,Wang Fubo,Lu Xin,Li Jia,Ye Guozhu,Yan Min,Zhuang Zhengping,Xu Chuanliang,Xu Guowang,Sun Yinghao

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Analytical Chemistry

Reference57 articles.

1. Imaging and intervention in prostate cancer: Current perspectives and future trends;Sharma;Indian J. Radiol. Imaging,2014

2. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells;Singh;Cancer Lett,2008

3. International trends and patterns of prostate cancer incidence and mortality;Hsing;Int. J. Cancer,2000

4. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression;Ding;Nature,2011

5. Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice;Rantalainen;J. Proteome Res,2006

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomics and metabolomics analysis of American shad (Alosa sapidissima) liver responses to heat stress;Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology;2024-10

2. Sialylation Inhibition Can Partially Revert Acquired Resistance to Enzalutamide in Prostate Cancer Cells;Cancers;2024-08-24

3. Taurine and proline promote lung tumour growth by co-regulating Azgp1/mTOR signalling pathway;2024-08-10

4. Pharmacological targets of SGLT2 inhibition on prostate cancer mediated by circulating metabolites: a drug-target Mendelian randomization study;Frontiers in Pharmacology;2024-08-06

5. Metabolic Disturbances in a Mouse Model of MPTP/Probenecid-Induced Parkinson’s Disease: Evaluation Using Liquid Chromatography-Mass Spectrometry;Neuropsychiatric Disease and Treatment;2024-08